On a roll, As­traZeneca flags loom­ing ap­provals for three big drug fran­chis­es

As­traZeneca cel­e­brat­ed a PR tri­fec­ta Mon­day morn­ing, nab­bing a pair of EU rec­om­men­da­tions for two of their lat­est block­busters along with a pri­or­i­ty re­view for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER